Aging
Navigate
Submit an Article
Research Paper|Volume 12, Issue 11|pp. 10844–10862
Aberrantly glycosylated integrin α3β1 is a unique urinary biomarker for the diagnosis of bladder cancer
Back to articleFigure 1(1 of 4)
100%
Figure 1
Figure 1.Patient selection process and classification. Overall patient selection process and their classification based on types of diseases.